Grifols SA (GRFS)
8.72
+0.03
(+0.35%)
USD |
NASDAQ |
Nov 16, 16:00
8.72
0.00 (0.00%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly) : 0.2739 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.2739 |
| June 30, 2026 | 0.2631 |
| March 31, 2026 | 0.1255 |
| December 31, 2025 | 0.168 |
| September 30, 2025 | 0.2183 |
| June 30, 2025 | 0.1952 |
| March 31, 2025 | 0.0924 |
| December 31, 2024 | 0.1081 |
| September 30, 2024 | 0.0836 |
| June 30, 2024 | 0.0235 |
| March 31, 2024 | 0.0342 |
| December 31, 2023 | 0.0895 |
| September 30, 2023 | 0.0896 |
| June 30, 2023 | 0.0612 |
| March 31, 2023 | -0.0168 |
| March 31, 2021 | 0.2286 |
| December 31, 2020 | 0.2314 |
| September 30, 2020 | 0.4566 |
| June 30, 2020 | 0.0513 |
| March 31, 2020 | 0.3001 |
| December 31, 2019 | 0.3265 |
| September 30, 2019 | 0.2219 |
| June 30, 2019 | 0.2833 |
| March 31, 2019 | 0.1899 |
| December 31, 2018 | 0.2142 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.254 |
| June 30, 2018 | 0.3058 |
| March 31, 2018 | 0.2578 |
| December 31, 2017 | 0.4003 |
| September 30, 2017 | 0.2702 |
| June 30, 2017 | 0.2313 |
| March 31, 2017 | 0.2091 |
| December 31, 2016 | 0.2155 |
| September 30, 2016 | 0.2344 |
| June 30, 2016 | 0.2258 |
| March 31, 2016 | 0.1985 |
| December 31, 2015 | 0.208 |
| September 30, 2015 | 0.2279 |
| June 30, 2015 | 0.2157 |
| March 31, 2015 | 0.2136 |
| December 31, 2014 | 0.2373 |
| September 30, 2014 | 0.2186 |
| June 30, 2014 | 0.2057 |
| March 31, 2014 | 0.2411 |
| December 31, 2013 | 0.1565 |
| September 30, 2013 | 0.1655 |
| June 30, 2013 | 0.1763 |
| March 31, 2013 | 0.1782 |
| December 31, 2012 | 0.1167 |
| September 30, 2012 | 0.1191 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -0.2068 |
| Evaxion AS | -0.4464 |
| DBV Technologies SA | -0.7143 |
| Cellectis SA | -0.2165 |
| Akari Therapeutics Plc | -1.599 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 208.24M |
| Revenue (Quarterly) | 2.347B |
| Total Expenses (Quarterly) | 2.161B |
| Enterprise Value | 14.98B |
| Gross Profit Margin (Quarterly) | 39.56% |
| Profit Margin (Quarterly) | 8.87% |
| Earnings Yield | 9.52% |
| Operating Earnings Yield | 24.38% |
| Normalized Earnings Yield | 9.524 |